Amgen Inc (AMGN) - News Archive

In a remarkable development within the biopharmaceutical sector, Amgen (NASDAQ:AMGN) and Kyowa Kirin Co., Ltd. (TSE:4151) have disclosed preliminary top-line results from the ASCEND Phase 3 long-term extension study. Th...

The field of oncology has seen remarkable innovations in recent years, particularly in the realm of targeted immunotherapy. A significant development has emerged with Asher Biotherapeutics announcing a clinical trial co...